[Investigation of hepatic reserve in patients with severe liver dysfunction in the treatment of acute leukemia].
Hamazaki
H
H
Horiuchi
F
F
Shimotsuma
N
N
Fujimoto
T
T
Maeda
Y
Y
Tsubaki
K
K
Irimajiri
K
K
Horiuchi
A
A
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D003561:Cytarabine / Q000009:adverse effects / Q000031:analogs & derivatives; D003843:Deoxycytidine Monophosphate / Q000009:adverse effects; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D008099:Liver / Q000503:physiopathology*; D008107:Liver Diseases / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D003561:Cytarabine; D003843:Deoxycytidine Monophosphate; C015019:enocitabine